Research Article

High Levels of Proinflammatory Cytokines, but Not Markers of Tissue Injury, in Unaffected Intestinal Areas from Patients with IBD

Table 1

Clinical information from IBD patients included in the study according to the Montreal classification [13]. Age groups: A2 17–40 years, and A3 > 40 years. UC affected area: E1 proctitis, E2 left colitis or rectosigmoditis (E2-RS), and E3 pancolitis. UC grade: S1 mild colitis, S2 moderate colitis, and S3 severe colitis. CD affected area: L1 terminal ileon, L2 colon, L3 ileocolonic, and “p” periananal affectation. CD presentation: B1 nonstricturing and nonpenetrating (formerly known as inflammatory), B2 stricturing, and B3 penetrating.

Ulcerative colitis

Case No.Age groupSexBiopsy availability (affected/unnafected areas)UC gradeAffected areaTreatment

UC-1A3MBothS1E2-RS5-ASA
UC-2A2MBothS3E2-RSNone
UC-3A2MBothS3E2None
UC-4A3MBothS1E25-ASA
UC-5A3MBothS3E2None
UC-6A3MBothS2E1None
UC-7A2FBothS3E2None
UC-8A3MBothS3E15-ASA
UC-9A2MBothS2E1None
UC-10A3MBothS1E15-ASA
UC-11A2MBothS2E3Methylprednisone
UC-12A3MBothS3E2None
UC-13A2MBothS2E15-ASA
UC-14A2MBothS1E2-RSNone
UC-15A3MBothS2E2Methylprednisone
UC-16A3FBothS3E15-ASA
UC-17A2MBothS3E15-ASA
UC-18A3MBothS3E35-ASA
UC-19A2MBothS2E25-ASA
UC-20A2FBothS3E1None
UC-21A3MBothS3E25-ASA
UC-22A3FBothS1E2-RSNone
UC-23A2FAffec. onlyS3E35-ASA
UC-24A2FAffec. onlyS2E25-ASA
UC-25A3MAffec. onlyS2E25-ASA
UC-26A3MAffec. onlyS2E15-ASA

Crohn’s disease

Case No.Age groupSexBiopsy availability (affected/unnafected areas)CD presentationAffected areaSurgeryTreatment

CD-1A2MBothB1L1NoNone
CD-2A3FBothB2L1NoNone
CD-3A3MBothB3L2YesBudesonide
CD-4A2FBothB1pL1YesTopic steroids + 5-ASA
CD-5A2MBothB1L1NoOral steroids
CD-6A2MBothB1L2No5-ASA
CD-7A2MBothB3L3YesBudesonide +5-ASA
CD-8A3FBothB1pL1YesTopic steroids + 5-ASA
CD-9A2FBothB2L1NoNone
CD-10A2FBothB1L1No5-ASA
CD-11A2FBothB1L1No5-ASA
CD-12A3MBothB3L1No5-ASA
CD-13A2FBothB1L1No5-ASA
CD-14A2FBothB1L1NoNone
CD-15A2MBothB1pL3YesTopic 5-ASA
CD-16A3MAffec. onlyB1L1No5-ASA